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30 The Journal of Thoracic and Cardiobjective: To ascertain long-term survival, identify risk factors for death, and
ocument complications of tracheostomy after cardiovascular surgery.
ethods: Between January 1, 1998, and September 1, 2001, 188 (1.4%) of 13,191
atients undergoing cardiovascular surgery had tracheostomy for respiratory failure
to 79 days (median, 14 days) after surgery. Factors associated with mortality were
dentified in the hazard function domain, and mode of death and complications of
racheostomy were determined by follow-up.
esults: Survival was 75%, 50%, and 31% at 30 days, 3 months, and 2 years,
espectively. The most important risk factors for death were older age (P  .004)
nd variables representing deteriorating hemodynamic (P  .0001), respiratory
P  .0001), and renal (P  .0001) function between the index cardiovascular
peration and tracheostomy. The mode of death was isolated respiratory failure in
nly 21 (16%) of 130 patients, but multisystem organ failure in 71 (55%). Follow-up
f 58 survivors identified voice complaints in 13 (24%), tracheal stenosis in 5
9.2%), and permanent tracheostomy in 3 (6%).
onclusions: Only one third of patients undergoing tracheostomy after cardiovas-
ular surgery survive, because it is used primarily in those with deteriorating
unction of multiple organ systems. Although tracheostomy may enhance patient
omfort and simplify nursing care, selection algorithms need to be developed if
urvival is the goal of the intervention.
racheostomy for patients admitted to medical intensive care units (ICUs) is
associated with favorable short-term outcomes.1-4 In contrast, few data are
available on the short- and long-term outcome of tracheostomy in the
ardiovascular surgery ICU setting.5,6 In medical ICUs, a favorable short-term
utcome may reflect careful triage; in cardiovascular surgery ICUs, respiratory
ailure is a less anticipated event for which tracheostomy may be more liberally
sed. Therefore, the purposes of this study were to determine time-related survival
fter tracheostomy after cardiovascular surgery, identify risk factors for death and
scertain mode of death, and document early and late complications of tracheos-
omy. With this information, we sought to identify patients most likely to survive
racheostomy after cardiovascular surgery.
atients and Methods
atients
etween January 1, 1998, and September 1, 2001, 188 (1.4%) of 13,191 patients undergoing
ardiovascular surgery at The Cleveland Clinic Foundation received 189 tracheostomies (1
atient had 2 tracheostomies 6 months apart, and these were considered as independent
ccurrences). Cardiac transplant patients and those with ventricular assist devices were not
ncluded.
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G
TSTo appreciate the changing nature of patient condition from
nitial operation to tracheostomy, information was gathered (1)
efore surgery, through the cardiovascular operation (Tables 1
nd 2), and immediately after the operation (initial admission to
CU; Tables 3 and 4) and (2) at tracheostomy, including interim
vents and changes in measurements and medications occurring
etween ICU admission and tracheostomy (Tables 5 and 6). Data
ere collected prospectively and concurrently with patient care
nd recorded in the Cardiothoracic Anesthesia Database, which
as been approved for research by the institutional review board.
hese data were supplemented by a detailed review of medical
ecords.
echnique of Tracheostomy
racheostomy was performed by an open technique, described
reviously.7 With few exceptions, the procedure was performed in
he operating room.
ollow-up
ollow-up was 93% complete (175 of 188 patients) and was
btained by review of medical records and telephone interviews
ABLE 1. Preoperative and intraoperative characteristics
f tracheostomy patients: categorical variables (n  189)
haracteristic No. (%)
ale 103 (55)
mergency operation 12 (6)
ardiac status
Severe LV dysfunction (EF 35%) 43 (23)
Pulmonary hypertension 36 (19)
Previous cardiac operation 71 (38)
oncardiac comorbidity
History of smoking 119 (63)
COPD/asthma 41 (22)
Hypertension 117 (62)
Stroke 34 (18)
Renal failure requiring dialysis 7 (4)
Diabetes 45 (24)
ardiac procedure
CABG 111 (59)
AV repair or replacement 62 (33)
Myectomy 2 (1)
MV repair or replacement 73 (39)
Thoracic aortic surgery 44 (23)
V, Aortic valve; CABG, coronary artery bypass grafting; COPD, chronic
bstructive pulmonary disease; EF, ejection fraction; LV, left ventricular;
Abbreviations and Acronyms
CL  confidence limit
ICU  intensive care unit
MSOFmultisystem organ failure
PEEP  positive end-expiratory pressureV, mitral valve. s
The Journal of Thoracicith patients, their families, or referring physicians by using
nstitutional review board–approved protocols and questionnaires.
or patients not traced, a search of the Social Security Death Index
as used to determine vital status.8,9 The mean and standard
eviation of follow-up among survivors was 2.1  0.99 years;
0% were followed more than 3.5 years. Outcome measures are
efined in Appendix 1.
ata Analysis
Descriptive statistics. Categorical variables are summarized by
requencies and percentages, and continuous variables are summa-
ized by means and standard deviations or medians and 15th and
5th percentiles. For consistency, coefficients in multivariable
odels are presented with 1 SE of the estimates, and probabilities
nd hazard estimates are accompanied by asymmetric 68% confi-
ence limits (CLs) equivalent to 1 SE.
Survival after tracheostomy. Estimates of survival were ob-
ained by the Kaplan-Meier method and by a parametric method
hat resolves the number of phases of instantaneous risk and esti-
ates shaping parameters.10 (For additional details, see http://www.
levelandclinic.org/heartcenter/hazard.)
ABLE 2. Preoperative characteristics of tracheostomy pa-
ients: continuous variables
haracteristic Mean  SD
emography
Age (y) 69 11
BMI (kg/m2) 27  6
erum chemistries
Albumin (g/dL) 3.6 0.68
Creatinine (mg/dL) 1.5 1.3
Bilirubin (mg/dL) 0.87 0.83*
MI, Body mass index. *Median (15th, 85th percentiles): 0.6 (0.4, 1.2).
ABLE 3. Characteristics of patients upon admission to the
ntensive care unit: categorical variables (n  189)
haracteristic No. (%)
edications given during first 24 h in ICU
Epinephrine 110 (58)
Milrinone 62 (33)
Dobutamine 17 (9)
Norepinephrine 89 (47)
Phenylephrine 11 (6)
Vasopressin 15 (8)
Lidocaine 16 (8)
Amiodarone 18 (10)
entilatory settings
Pressure control 25 (13)
CPAP 25 (13)
Assist control 5 (3)
SIMV 134 (71)
PAP, Continuous positive airway pressure; ICU, intensive care unit; SIMV,
ynchronized intermittent mandatory ventilation.
and Cardiovascular Surgery ● Volume 131, Number 4 831
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G
TSRisk factors for death after tracheostomy. To understand th
ffect of changing patient condition on factors associated 
ortality, a sequential analytic strategy was followed. The first
nalysis (sequence 1) was of preoperative, intraoperative, and ICU
dmission variables (Appendix 2). The second analysis (sequence
) added (1) interim events between ICU admission and tracheos-
omy and (2) patient condition at tracheostomy.
Continuous and ordinal variables were retained in their original
tate to maximize information content. Original measurement
cales were calibrated to assumptions of the analysis by transfor-
ation, as necessary (linearization).
Selection of factors for both analyses used bootstrap aggrega-
ion (bagging).11,12 Automated analyses of 1000 random data sets
ere performed by using P  .05 as the criterion for variable
etention. The resulting models were aggregated with results ex-
ressed as frequency of occurrence of both single factors and
losely related clusters of factors. We considered factors or clus-
ers appearing in at least 50% of analyses to be reliably statistically
ignificant. Interaction among variables was then studied in a
econd bagging process to produce final models.
Modes of death. Primary modes of death were considered
utually exclusive categories (Appendix 1). A hazard function for
ach mode was obtained, in an analysis of competing events,13 by
sing both nonparametric and parametric methodology.10,14
Likelihood of recovery after tracheostomy. The equation 
ulting from the multivariable analysis that included condition at
racheostomy (sequence 2) was solved across time to illustrate
atients most and least likely to recover after tracheostomy.
resentation
ontinuous variables are presented as mean  SD and, equiva-
ently, as 15th, 50th (median), and 85th percentiles when distribu-
ions are skewed. Categorical variables are presented as counts and
ercentages. Outcome events are accompanied by asymmetric
ABLE 4. Characteristics of patients on admission to the
ntensive care unit: continuous variables
haracteristic Mean  SD
entilatory settings
FIO2 (%) 66  14
PEEP (cm H2O) 5.8  1.7
Tidal volume (mL per breath) 826 155
lood gases
pH 7.38 0.073
PaCO2 (mm Hg) 42  7
PaO2 (mm Hg) 148 67
ore temperature (°C) 36 0.84
emodynamics
Heart rate (beats per minute) 96 14
Mean systemic arterial pressure (mm Hg) 79 13
Central venous pressure (mm Hg) 13 5
Pulmonary artery systolic pressure (mm Hg) 38 12
Pulmonary artery diastolic pressure (mm Hg) 20 7
Cardiac index (L · min1 · m2) 2.5  0.72
IO2, Fraction of inspired oxygen; PEEP, positive end-expiratory pressure.8% CLs equivalent to1 SE. Model coefficients are presented as f
32 The Journal of Thoracic and Cardiovascular Surgery ● Apri1 SE rather than as hazard ratios, in part because the model does
ot assume proportional hazards across time and in part because
inearizing transformations render hazard ratios difficult to inter-
ret. Rather, graphical presentation of results is used to illustrate
he multivariable models, values for specific patient variables
ubstituting into them to illustrate various scenarios described in
he text.
esults
urvival After Tracheostomy
urvival after tracheostomy was 75%, 50%, and 31% at 30
ays, 3 months, and 2 years, respectively (Figure 1). The
isk of death was highest in the first month after tracheos-
omy, and 67 patients (36%) died before hospital discharge
Figure E1).
isk Factors for Mortality
hen only preoperative, operative, and ICU admission
ariables were considered (sequence 1; Table 7), left heart
ailure and early milrinone requirement, but not the interval
ABLE 5. Characteristics of patients at tracheostomy: cat-
gorical variables
haracteristic No./n (% of n)
edications
Paralytics 4/187 (2)
Vasopressors 59/186 (32)
Nitric oxide 0/187 (0)
Antiarrhythmics 108/182 (59)
Inotropes 25/185 (14)
entilatory settings
Pressure control 95/183 (52)
CPAP 56/183 (31)
Assist control 2/183 (1)
SIMV 30/183 (16)
ardiac rhythm
Atrial fibrillation 39/189 (21)
Paced 45/189 (24)
nterim events
Stroke 28/181 (15)
Dialysis 50/185 (27)
utrition
Total parenteral 77/188 (41)
Enteral 104/188 (55)
nfections
Mediastinitis 8/184 (4)
Endocarditis 10/184 (5)
Pneumonia 116/184 (63)
Empyema 5/184 (3)
Urinary tract 18/184 (10)
Soft tissue 24/184 (13)
Bacteremia 49/184 (27)
PAP, Continuous positive airway pressure; SIMV, synchronized intermit-
ent mandatory ventilation.rom surgery to tracheostomy, were associated with in-
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G
TSreased mortality. However, from the time of ICU entry
ntil tracheostomy (the median interval from surgery to
racheostomy was 14 days; the highest probability of receiv-
ng it was on day 12), inotropic support generally decreased,
ntiarrhythmia medication use increased, 28 patients exhibited
ew neurologic deficits (15%), 50 patients required hemodial-
sis (27%), and 154 patients developed infections (82%). Pa-
ients were more often on pressure-controlled ventilation than
n synchronized intermittent mandatory ventilation, and there
igure 1. Percentage survival after tracheostomy. Each circle
epresents a death, and vertical bars represent asymmetric 68%
onfidence limits (CL). Numbers in parentheses are patients re-
aining at risk. The solid line is a parametric survival estimate
ABLE 6. Characteristics of patients at tracheostomy: con-
inuous variables
haracteristic Mean  SD
entilatory settings
FIO2 (%) 41  6.5
PEEP (cm H2O) 7.3  4.0
Tidal volume (mL per breath) 73.3 176
Rate (breaths per minute) 11 4.5
Pressure support (cm H2O) 9.8  5.5
Minute volume (L/min) 15 6.3
lood gases
pH 7.44 0.059
PaCO2 (mm Hg) 38  7.5
PaO2 (mm Hg) 109 31
emodynamics
Heart rate (beats per minute) 88 14
Mean arterial pressure (mm Hg) 75 11
Central venous pressure (mm Hg) 14 5.1
enal function
Creatinine (mg/dL) 1.9 1.4
IO2, Fraction of inspired oxygen; PEEP, positive end-expiratory pressure.(nclosed within 68% CLs.
The Journal of Thoracicas on average an increase in positive end-expiratory pressure
PEEP; P  .0001; Tables 3-6).
Therefore, when variables related to these interim events
nd changing conditions at the time of tracheostomy were
dded to the analysis (sequence 2; Table 7), factors related
o left heart failure and acidosis at ICU admission were no
onger risk factors; rather, condition at tracheostomy and
hange from ICU admission to tracheostomy dominated.
hese variables included renal dysfunction, nonweaning
entilator mode, and use of vasopressors. If patients re-
eived their tracheostomy relatively early (within the first
0 days of operation), the change in the level of PEEP was
nimportant; however, if they received tracheostomy late
4-7 weeks) after operation, then an increased PEEP re-
uirement was associated with worse survival (see interac-
ion term in Table 7 and Figure E2).
odes of Death
In-hospital death. Of the 67 patients who died in the
ospital, 49 (73%) died in multisystem organ failure
ABLE 7. Incremental risk factors for death after
racheostomy
isk factor* P value
equence 1: preoperative, operative, and ICU
admission variables
reoperative
Older age .06
t time of ICU admission
Use of milrinone in first 24 h .0006
Lower cardiac output .009
Lower FIO2 .02
Lower pH .004
Higher PaO2 .02
equence 2: addition of interim events, status at
tracheostomy, and change since ICU admission
reoperative
Older age .0004
t time of ICU admission
Use of milrinone in first 24 h .0009
t tracheostomy
Higher BUN .0001
Less pressure support .0001
Use of vasopressors .001
hange from ICU admission to tracheostomy
Interaction: PEEP change and interval from
operation to tracheostomy .02
Interval from operation to tracheostomy .8
PEEP change .6
Higher absolute mean arterial pressure change .0001
or details, see Table E1. BUN, Blood urea nitrogen; ICU, intensive care
nit; PEEP, positive end-expiratory pressure; FIO2, fraction of inspired
xygen. *Variables entered only into the early hazard phase.MSOF), and 7 (10%) died in respiratory failure (Table 8).
and Cardiovascular Surgery ● Volume 131, Number 4 833
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G
TSamilies of 43 patients (64%) withdrew support. No patient
as decannulated before death.
After hospital transfer or discharge. Of the 63 patients
ho died after hospital transfer or discharge, the most
ommon mode of death was MSOF (n 22; 45%; Table 8).
upport was withdrawn from 14 patients, and 19 were
ecannulated before death.
Competing modes of death. The risk of death in cardiac
ailure at any time after tracheostomy declined with time,
hereas MSOF peaked by approximately 2 weeks (Figure
). The risk of death in isolated respiratory failure peaked 1
onth after tracheostomy.
afety of Tracheostomy
In-hospital complications. There were no operative
omplications of tracheostomy. Superficial sternal wound
nfections developed in 3 patients (1.6%; CL, 0.7%-
.2%), and 1 patient (0.5%; CL, 0.07%-1.8%) underwent
eoperation for mediastinitis. Two patients (1.1%; CL,
.4%-2.5%) bled from the tracheal stoma: 1 required
ransfusion, and the other was readmitted to the ICU for
bservation.
After hospital transfer or discharge. Ascertainment of
racheostomy-related complications was possible in 109
90%) of 121 discharged patients. Their most common
omplaint was a change in the quality or character of the
oice (n  14; 13%; CL, 9.5%-17%). Eleven noted hoarse-
ess, 2 thought their voices were weak, and 1, a singer, had
normal speaking voice but had lost vocal range. Five
atients (4.6%; CL, 2.6%-7.7%) had tracheal stenosis, 3 of
hem with permanent tracheostomies. Three patients (2.8%;
L, 1.2%-5.5%) self-decannulated in a skilled nursing fa-
ility. This led to death in 2 and emergency tube replace-
ent in the third. Two patients (1.8%; CL, 0.6%-4.3%) bled
rom the tracheal stoma; tracheomalacia was documented in
. One patient (0.9%; CL, 0.1%-3.1%) developed medias-
initis 2 months after tracheostomy and several weeks after
ospital discharge, and 1 had a resolving tracheocutaneous
ABLE 8. Modes of death after tracheostomy
ode
In hospital
(n  67)*
After transfer
or discharge
(n  63)†
SOF 49 (73) 22 (45)
espiratory failure 7 (10) 14 (27)
eart failure 6 (9.0) 11 (20)
eurologic 3 (4.4) 2 (3.6)
astrointestinal 2 (3.0) 2 (3.6)
SOF, Multisystem organ failure. *Data are No. (%). †Data are No. (% of
1); mode of death could not be determined in 12 cases.stula 1 year after decannulation. f
34 The Journal of Thoracic and Cardiovascular Surgery ● Apriiscussion
rincipal Findings
racheostomy for respiratory failure after cardiovascular
urgery is performed in a group of patients at exceptionally
igh risk of early death. Patients whose condition worsens
rom the index operation until tracheostomy experience the
ighest mortality, and the mode of death is most often
SOF. The tracheostomy itself is a safe procedure with few
ong-term sequelae in patients who survive.
Survival after tracheostomy. Nearly two thirds of pa-
ients who received tracheostomy died within the first year:
alf in the hospital and half after discharge or transfer. This
llustrates the severity of the illness and the limited ability to
alvage patients who experience MSOF after cardiovascular
urgery.
In some acute settings, tracheostomy has been associated
ith lower mortality in the ICU.1-4 However, the long-term
rognosis of these patients is likely to be poor.15-19 Although
e had hypothesized that we were using tracheostomy more
iberally (without triage) than critical care physicians in med-
cal ICUs, long-term survival seems to be similar in both
ettings. Nevertheless, the one third of our patients who have
urvived self-report good functional status.
Risk factors for mortality after tracheostomy. A unique
spect of this study is that the changing condition of the
atient was considered in a sequential analysis of risk fac-
ors for mortality after tracheostomy. Another is that we
ave quantified the importance of the changing condition of
he patient from time of entry into the ICU until tracheos-
omy. Specifically, preoperative, intraoperative, and early
ostoperative risk factors for death were largely superseded
y factors reflecting patient condition at tracheostomy. Risk
igure 2. Instantaneous risk of death (hazard function) in various
odes after tracheostomy. For clarity, the horizontal axis has been
xpanded to depict only the first 6 months after tracheostomy.actors based only on the first analysis (sequence 1) were
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G
TSot highly discriminating. That analysis emphasized that
part from older age, a risk factor previously identified,15,17
he primary risk factor for death was hemodynamic status,
articularly right or left ventricular failure (Table 7). Vari-
bles relating to respiratory state were less reliably associ-
ted with outcome.
However, when events that occurred between the index
peration and tracheostomy, status of the patient at trache-
stomy, and absolute change of multiple hemodynamic and
espiratory variables were added to the analysis (sequence
; Table 7), the importance of changed patient condition
ith respect to MSOF (respiratory, cardiac, and renal) was
ppreciated. Except for early use of milrinone, all variables
rom sequence 1 that related to patient status at the end of
he index operation were far less important. It is interesting
o note that intervening clinical events (infection, neuro-
ogic, renal, and parenteral and enteral nutrition) were not
dentified directly as risk factors, but were likely reflected
n multisystem dysfunction. Clearly, the patient whose
ondition deteriorates throughout the postoperative pe-
iod is unlikely to recover after tracheostomy.
Variation in the timing of tracheostomy was not associ-
ted with outcome, as was also found by Brook and col-
eagues2 and suggested by others.3,4 However, hospital
osts may be decreased by early tracheostomy, despite its
ack of effect on survival.2
Modes of death. Another important contribution of this
tudy is characterizing the mode of death in a temporal,
ompeting-risks fashion. Most deaths early and late after
racheostomy were from MSOF. Only 10% of in-hospital
eaths and 27% of postdischarge deaths were attributable to
solated respiratory failure (Table 8 and Figure 2). Clearly,
eath from pulmonary failure is delayed by the use of
echanical ventilatory support, but death from cardiac or
ultisystem failure is less preventable.
Safety of tracheostomy. An open technique of tracheos-
omy was used for all patients.7 This approach proved to be
asy, safe, and seldom complicated. It is interesting to note
hat unlike Curtis and colleagues,6 we found no association
f tracheostomy with mediastinitis, even though we used an
pen rather than a percutaneous technique.
Long-term sequelae of tracheostomy were few. Sur-
risingly, most long-term survivors had no complaints
fter decannulation; among those who did, the most
requent was a change in voice. These few late posttra-
heostomy complications contrast with vocal sequelae in
ore than one quarter of patients after percutaneous
ilatational tracheostomy.20
imitations
his study centers on the experience of a single high-
olume institution and has typical institutional biases re-
arding patient selection. Data collected from long-term o
The Journal of Thoracicentilator facilities were often limited to mode of death.
ssumptions regarding the mode of death of transferred
atients whose families decided to terminate life support
elied on noninstitution physician assessment.
Survival after tracheostomy was a primary end point.
here are other outcomes to consider, including patient
omfort, advancement of oral nutrition, decreased use of
edation, improved patient–family communication, and
implified nursing and respiratory care. However, because
one of these end points could be easily abstracted and
uantified, analyses were not possible. In addition, the date
f death for patients who died of respiratory failure is
omewhat artificial, reflecting in part family wishes to ter-
inate support of chronically ventilator-dependent patients.
ecommendations
ndications for tracheostomy generally have been based on
he duration of invasive mechanical ventilation, indepen-
ently of the underlying disease. They reflect historical data
hat tracheostomy reduced laryngotracheal injury from pro-
racted orotracheal intubation.4,21-23 Are there indications
or tracheostomy that can be based on survival as the
mportant outcome? Figure 3 illustrates the survival, de-
ived from our analysis, of 3 typical, but hypothetical,
atients with different clinical scenarios (Table 7). The
reatest survival benefit of tracheostomy after cardiovascu-
ar surgery is realized by relatively young patients with no
arly milrinone requirement and with, at the time of trache-
stomy, normal blood urea nitrogen, no vasopressors with
igher blood pressure, and improved respiratory mechanics
less PEEP and lower pressure support requirements; patient
). A minimal survival benefit is realized by the older
atient with persistent cardiac, pulmonary, and renal dys-
unction at tracheostomy (patient C), and variable survival
enefit is realized for patients intermediate between these,
uch as patient B.
Other possible, but less tangible, benefits of tracheos-
omy include simplified nursing care, improved pulmonary
oilet, reduced occurrence of pneumonia, superior airway
ecurity, and expedited ventilatory weaning.24 In addition,
racheostomy may promote early transfer to a chronic ven-
ilation facility to allow more efficient allocation of re-
ources, may reduce the need for sedation, and facilitates
ommunication between patient and family. Unfortunately,
one of these indications is well documented or easily
nvestigated.
Conflicting information exists regarding whether trache-
stomy is lifesaving.15,19 Indeed, decisions regarding tra-
heostomy after cardiovascular surgery should consider not
nly survival, but also patient comfort and nursing issues.
owever, consideration for tracheostomy earlier in the post-
perative course may prevent some patients from deterio-
and Cardiovascular Surgery ● Volume 131, Number 4 835
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G
TSating to the point of no return, thus decreasing the number
f futile or merely supportive tracheostomies.
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ardiothoracic Anesthesia Database team; Tanya Ashinhurst for
egistry assistance; Angela York, Linda DiPaola, MS, and Chris-
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ppendix 1: Definitions of Outcome Measures
nfections
Mediastinitis. Fever, sternal instability, and purulent drainage
rom the sternal wound requiring reoperation
Endocarditis. Fever associated with valve vegetations on
chocardiogram and positive blood cultures
Pneumonia. Positive sputum culture and infiltrates on chest
adiograph associated with fever, copious sputum production,
nd/or leukocytosis, for which antibiotic therapy is instituted
Empyema. Purulent material in the pleural space confirmed by
ultures from chest tube drainage or thoracentesis
Urinary tract infection. Positive urine cultures for which an-
ibiotics are prescribed
Soft tissue infection. Purulent drainage with positive cultures
nd institution of therapy, exclusive of mediastinal wounds
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TSBacteremia. Bacteria grown from blood cultures, for which
ntibiotic therapy is instituted
omplications
Superficial sternal wound infection. Drainage or cellulites for
hich antibiotics are given and/or for which the wound is opened
nd packed at bedside
Mediastinitis. Fever, sternal instability, and purulent drainage
rom the sternal wound for which the patient is returned to the
perating room
Bleeding. Bleeding from the airway any time after tracheos-
omy requiring reoperation or transfusion
Voice. Self-assessment of a change in the strength or character
f one’s voice after decannulation
Self-decannulation. Unplanned removal of tracheostomy by
he patient, resulting in adverse sequelae such as a readmission to
he hospital, translaryngeal reintubation, hypoxia, or death
Tracheal stenosis. Dyspnea, stridor, or both, with stenosis at the
toma or below documented by fiber-optic visualization of the airway
Tracheomalacia. Persistent leak around the tracheostomy bal-
oon, or dyspnea, and malacia documented by fiber-optic exami-
ation of the airway
Tracheocutaneous fistula. Persistent stoma more than 6
onths after decannulation
odes of Death
Neurologic. Stroke or intracerebral bleed documented by the
onsulting neurologist and head computed tomographic scan
Cardiac. Isolated persistent cardiogenic shock defined by
ome combination of acidosis (pH 7.35), low cardiac index
2.0 L · min1 · m2), ejection fraction less than 30%, or
ependence on inotropes
Respiratory. Isolated persistent respiratory failure defined by
aO2 less than 60 mm Hg, PaCO2 greater than 50 mm Hg;
ersistent diffuse infiltrates on chest radiograph or pneumonia;
nability to wean from the ventilator; and, in 1 case, pulmonary
mbolus
Gastrointestinal. Isolated intra-abdominal catastrophe such as
astrointestinal bleeding, ischemia, or perforated viscus
Multisystem organ failure. Failure of 3 or more of the follow-
ng organ systems:
1. Circulatory: defined by persistent cardiogenic shock
2. Respiratory: as defined previously
3. Renal: defined as serum creatinine greater than 3.0 mg/dL,
anuria, or new-onset dialysis (hemodialysis or continuous
venovenous hemodialysis)
4. Liver, defined by bilirubin greater than 6 mg/dL or aspartate
aminotransferase greater than 500 units/L
5. Gastrointestinal, manifest as bleeding, ischemia, or intra-
abdominal sepsis
6. Immunologic, defined as persistent culture-positive infec-
tion and sepsis
ppendix 2: Variables Used in Analyses
reoperative
Demography. Sex, age at operation (years), height (centime-
ers), and weight (kilograms)
The Journal of ThoracicClinical condition. Emergency operation
Cardiac status. Left ventricular function
Cardiac comorbidity. Pulmonary hypertension and number of
revious cardiac operations
Noncardiac comorbidity. Serum albumin (grams per decili-
er), blood urea nitrogen (milligrams per deciliter), creatinine (mil-
igrams per deciliter), bilirubin (milligrams per deciliter), hemat-
crit (percentage), chronic obstructive pulmonary disease/asthma,
istory of heart failure, hypertension, history of smoking, stroke,
iabetes (diet controlled, oral hypoglycemic treatment, insulin
reatment), and dysrhythmia
ardiac Procedure
Coronary artery bypass grafting, aortic valve replacement,
itral valve repair, mitral valve replacement, thoracic aortic
urgery, cardiopulmonary bypass time, and aortic clamp time
xperience
Date of operation (years since January 1, 1997)
pon Admission to the Intensive Care Unit
Cardiac status. Cardiac output (liters per minute), cardiac in-
ex (liters per minute per square meter), central venous pressure
millimeters of mercury), heart rate (beats per minute), pulmonary
rtery diastolic pressure (millimeters of mercury), pulmonary ar-
ery systolic pressure (millimeters of mercury), and mean systemic
rterial pressure (millimeters of mercury)
Patient status. Ventricular rate (beats per minute), ventilatory
upport (mode), positive end-expiratory pressure (centimeters of
ater), tidal volume, fraction of inspired oxygen, core temperature
degrees centigrade), pH, PaCO2, PaO2, and HCO3
Medications given in intensive care unit (first 24 hours). Amio-
arone, dobutamine, epinephrine, lidocaine, milrinone, norepi-
ephrine, phenylephrine, and vasopressin
t Tracheostomy
Cardiac status. Cardiac rhythm, central venous pressure (mil-
imeters of mercury), heart rate (beats per minute), mean systemic
rterial pressure (millimeters of mercury), cardiac output (liters per
inute), and cardiac index (liters per minute per square meter)
Patient status. Ventricular rate (beats per minute), ventilatory
upport (mode), positive end-expiratory pressure (centimeters of
ater), fraction of inspired oxygen, tidal volume, mandatory ven-
ilation, pressure control, pressure support, pH, PaCO2, HCO3

,
nd PaO2
Medications. Inotropes, antiarrhythmics, nitric oxide, paralyt-
cs, and vasopressors
Infection. Bacteremia, empyema, endocarditis, mediastinitis,
neumonia, soft tissue infection, and urinary tract infection
Neurologic. Stroke, encephalopathy, and spinal injury
Renal. Dialysis dependence, blood urea nitrogen (milligrams
er deciliter), and creatinine (milligrams per deciliter)
Nutrition. Total parenteral nutrition and enteral feed
Interval. Operation to tracheostomy (days)
and Cardiovascular Surgery ● Volume 131, Number 4 837
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isk factor* Coefficient  SE P value Reliability (%)†
equence 1: preoperative, operative, and ICU admission variables
reoperative
Older age‡ 0.23 0.12 .06 32
t time of ICU admission
Use of milrinone in first 24 h 0.63 0.18 .0006 80
Lower cardiac output§ 0.88 0.34 .009 66
Lower FIO2 1.7  0.71 .02 37
Lower pH¶ 27  9.4 .004 37
Higher PaO2# 0.11 0.051 .02 39
equence 2: addition of interim events, status at tracheostomy,
and change since ICU admission
reoperative
Older age‡ 0.43 0.12 .0004 52
t time of ICU admission
Use of milrinone in first 24 h 0.62 0.19 .0009 57
t tracheostomy
Higher BUN** 0.53 0.14 .0001 94
Less pressure support (cm H2O)†† 0.11 0.029 .0001 53
Use of vasopressors 0.63 0.19 .001 55
hange from ICU admission to tracheostomy
nteraction: PEEP change and interval from operation to
tracheostomy‡‡ 0.012 0.0052 .02 85
Interval from operation to tracheostomy§§ 0.0069 0.023 .8
PEEP change 0.012 0.021 .6
Higher absolute mean arterial pressure change 0.076 0.015 .0001 70
UN, Blood urea nitrogen; ICU, intensive care unit; FIO2, fraction of inspired oxygen; PEEP, positive end-expiratory pressure. *Variables entered only into
he early hazard phase. †Percentage of bootstrap models in which the variable appeared. ‡Exp(age/50) exponential transformation. §Cardiac output/5.
(60/FIO2) inverse transformation. ¶Ln(pH) logarithmic transformation. #(PaO2/130)2 squared transformation. **BUN/50. ††(10/Pressure support) inverse
ransformation. ‡‡PEEP difference · exp(interval from operation to tracheostomy/17). §§Exp(interval from operation to tracheostomy/17) exponential
ransformation. (Mean arterial pressure difference)2 squared transformation.
Figure E1. Instantaneous risk of death (hazard function) enclosed within 68% confidence limits.37.e1 The Journal of Thoracic and Cardiovascular Surgery ● April 2006
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Walts et al General Thoracic Surgeryigure E2. Interplay of the timing of tracheostomy and the change
n ventilatory states at tracheostomy compared with those at
ntensive care unit admission as they affected 1-year survival.
his is an illustration of the multivariable equation for death
Table 7; sequence 2). The top curve (with confidence limits
quivalent to 1 SE) shows the effect of decreased positive end-
xpiratory pressure (PEEP), whereas the bottom curve shows the
ffect of increased PEEP.
The Journal of Thoracic and Cardiovascular Surgery ● Volume 131, Number 4 837.e2
G
TS
